Jaguar Health (JAGX) Gross Profit Growth (1y) (2016 - 2026)
Jaguar Health (JAGX) Gross Profit Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | 41.37% |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn | 7.76% |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn | 16.94% |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn | 68.41% |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn | 83.14% |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - | - |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn | 1,025.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,025.01% |
| Dec 31, 2025 | -64.94% |
| Sep 30, 2025 | -0.62% |
| Jun 30, 2025 | 6.89% |
| Mar 31, 2025 | -11.56% |
| Dec 31, 2024 | 83.01% |
| Sep 30, 2024 | 11.66% |
| Jun 30, 2024 | 7.40% |
| Mar 31, 2024 | 740.33% |
| Dec 31, 2023 | 448.38% |
| Sep 30, 2023 | -8.77% |
| Jun 30, 2023 | -13.35% |
| Mar 31, 2023 | 31.03% |
| Dec 31, 2022 | -128.74% |
| Sep 30, 2022 | 126,100.00% |
| Jun 30, 2022 | 964.91% |
| Mar 31, 2022 | -169.60% |
| Dec 31, 2021 | -9.85% |
| Sep 30, 2021 | 99.74% |
| Jun 30, 2021 | 71.98% |